✦ LIBER ✦

PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

✍ Scribed by L. Betegon; I. Gilloteau; P. Martin; A. Woolmore; I. Oyagüez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line treatment of chronic myeloid

✍ Nicholas J. DiBella 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 108 KB

First-line treatment for chronic myeloid

✍ Guoqing Wei; Shamudheen Rafiyath; Delong Liu 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 298 KB

PCN60 Cost Effectiveness of Nilotinib, D

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLE

✍ K El Ouagari; W Talbot; JF Baladi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Dasatinib in the first-line treatment of

✍ Patricia Ault 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 264 KB

Six-year follow-up of patients receiving

✍ Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Gold 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB